The present invention relates to a method for purifying recombinant HCV single or specific oligomeric envelope proteins selected from the group consisting of E1 and/or E1/E2 characterized in that upon lysing the transformed host cells to isolate the recombinantly expressed protein a disulphide bond cleavage or reduction step is carried out with a disulphide bond cleavage agent. The present invention also relates to a composition isolated by such a method. The present invention also relates to the diagnostic and therapeutic application of these compositions. Furthermore, the invention relates to the use of HCV E1 protein and peptides for prognosing and monitoring the clinical effectiveness and/or clinical outcome of HCV treatment.

 
Web www.patentalert.com

< Recombinant tumor specific antibody and use thereof

< High affinity fusion proteins and therapeutic and diagnostic methods for use

> Engineered protein kinases which can utilize nucleotide triphosphate substrates

> Lipid structures and uses thereof

~ 00251